News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akonni Biosystems Awarded $3M Akonni Biosystems Challenge Grant to Develop Rapid Molecular Test for Genotyping MDR/XDR-TB


9/28/2010 12:03:15 PM

FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for complex infectious and human diseases, today announced receipt of a nearly $3 million Challenge Grant from the National Institutes of Health (NIH), a new program made possible under the American Recovery and Reinvestment Act (ARRA). Selected from well over 20,000 applications, these funds will enable Akonni to advance the development of its multi-drug resistant/extensively drug-resistant (MDR/XDR) genotyping test through pre-clinical testing at several international field sites, including sites such as the Medical Research Council of South Africa (MRC).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES